688276 Stock Overview
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 1/6 |
Changchun BCHT Biotechnology Co. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥39.07 |
52 Week High | CN¥71.50 |
52 Week Low | CN¥38.21 |
Beta | -0.12 |
1 Month Change | -12.20% |
3 Month Change | -15.78% |
1 Year Change | -44.19% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -37.41% |
Recent News & Updates
Recent updates
Shareholder Returns
688276 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 1.3% | 2.6% | 1.2% |
1Y | -44.2% | -19.6% | -12.6% |
Return vs Industry: 688276 underperformed the CN Biotechs industry which returned -19.6% over the past year.
Return vs Market: 688276 underperformed the CN Market which returned -12.6% over the past year.
Price Volatility
688276 volatility | |
---|---|
688276 Average Weekly Movement | 6.5% |
Biotechs Industry Average Movement | 7.8% |
Market Average Movement | 8.5% |
10% most volatile stocks in CN Market | 12.5% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 688276's share price has been volatile over the past 3 months.
Volatility Over Time: 688276's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 1,241 | Wei Kong | www.bchtpharm.com |
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. Its products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. The company was founded in 2004 and is based in Changchun, China.
Changchun BCHT Biotechnology Co. Fundamentals Summary
688276 fundamental statistics | |
---|---|
Market cap | CN¥16.16b |
Earnings (TTM) | CN¥543.19m |
Revenue (TTM) | CN¥1.92b |
29.8x
P/E Ratio8.4x
P/S RatioIs 688276 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688276 income statement (TTM) | |
---|---|
Revenue | CN¥1.92b |
Cost of Revenue | CN¥212.81m |
Gross Profit | CN¥1.70b |
Other Expenses | CN¥1.16b |
Earnings | CN¥543.19m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.31 |
Gross Margin | 88.89% |
Net Profit Margin | 28.36% |
Debt/Equity Ratio | 1.6% |
How did 688276 perform over the long term?
See historical performance and comparison